Zobrazeno 1 - 10 of 95 pro vyhledávání: '"Peter, Hotez"'
1
Akademický článek
Anti‐science conspiracies pose new threats to US biomedicine in 2023
Autor: Peter Hotez
Publikováno v: FASEB BioAdvances, Vol 5, Iss 6, Pp 228-232 (2023)
Externí odkaz: https://doaj.org/article/45c6134b75574d159d0853c1e2ccac39
Zobrazit plný text záznamu
2
Akademický článek
Vaccines and therapeutics for immunocompromised patients with COVID-19
Autor: Shmuel Shoham, Carolina Batista, Yanis Ben Amor, Onder Ergonul, Mazen Hassanain, Peter Hotez, Gagandeep Kang, Jerome H. Kim, Bhavna Lall, Heidi J. Larson, Denise Naniche, Timothy Sheahan, Nathalie Strub-Wourgaft, Samba O. Sow, Annelies Wilder-Smith, Prashant Yadav, Maria Elena Bottazzi
Publikováno v: EClinicalMedicine, Vol 59, Iss , Pp 101965- (2023)
Summary: The COVID-19 pandemic has disproportionately impacted immunocompromised patients. This diverse group is at increased risk for impaired vaccine responses, progression to severe disease, prolonged hospitalizations and deaths. At particular ris
Externí odkaz: https://doaj.org/article/1eb50f891ae54256b5ca44e837ea4014
Zobrazit plný text záznamu
3
Akademický článek
XBB.1.5 emerges in the Americas: what it means to the region
Autor: Peter Hotez
Publikováno v: The Lancet Regional Health. Americas, Vol 18, Iss , Pp 100433- (2023)
Externí odkaz: https://doaj.org/article/6dcc291a339142ab83967ffa304a0249
Zobrazit plný text záznamu
4
Akademický článek
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
Autor: Victor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, Miguel Enrique Rosado-Vallado, Victor Ermilo Arana-Argaez, Jaime Ortega-Lopez, Fabian Gusovsky, Eric Dumonteil, Julio Vladimir Cruz-Chan, Peter Hotez, María Elena Bottazzi, Liliana Estefania Villanueva-Lizama
Publikováno v: PLoS Neglected Tropical Diseases, Vol 16, Iss 9, p e0010258 (2022)
BackgroundChagas disease (CD) is caused by Trypanosoma cruzi and affects 6-7 million people worldwide. Approximately 30% of chronic patients develop chronic chagasic cardiomyopathy (CCC) after decades. Benznidazole (BNZ), one of the first-line chemot
Externí odkaz: https://doaj.org/article/374146e448344e15b0bf078cd3e7e089
Zobrazit plný text záznamu
7
Akademický článek
Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Schistosoma mansoni Tetraspanin 2 vaccine
Autor: Guangzhao Li, Lara Hoeweler, Brian Keegan, Jin Peng, Larissa Scholte, Peter Hotez, Maria Elena Bottazzi, David Diemert, Jeffrey Bethony
Publikováno v: Vaccine: X, Vol 8, Iss , Pp 100100- (2021)
Introduction: As a primary stability-indicating parameter, potency should be strategically evaluated during each phase of vaccine development. Herein, we present potency testing during the early clinical development of the Schistosoma mansoni (Sm) Te
Externí odkaz: https://doaj.org/article/702f3e9a9f204d74a8d01630d3e6a387
Zobrazit plný text záznamu
8
Akademický článek
Operation Warp Speed: implications for global vaccine security
Autor: Jerome H Kim, Peter Hotez, Carolina Batista, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, Mayda Gursel, Mazen Hassanain, Gagandeep Kang, Bhavna Lall, Heidi Larson, Denise Naniche, Timothy Sheahan, Shmuel Shoham, Annelies Wilder-Smith, Nathalie Strub-Wourgaft, Prashant Yadav, Maria Elena Bottazzi
Publikováno v: The Lancet Global Health, Vol 9, Iss 7, Pp e1017-e1021 (2021)
Summary: Several global efforts are underway to develop COVID-19 vaccines, and interim analyses from phase 3 clinical testing have been announced by nine organisations: Pfizer, the Gamaleya Research Institute of Epidemiology and Microbiology, Moderna
Externí odkaz: https://doaj.org/article/f27b76dbef9746aba672ffc480c7888f
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje